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Abstract
Background: Worldwide, L. pneumophila sg 1 is the most common agent of Legionnaires’ disease ( 80 to 90% of
the reported cases). In contrast, L. pneumophila sg 2–14 account for only 15 to 20% of community-acquired cases,
although they account for over 50% of the environmental isolates. The discrepancy between environmental isolates
and clinical cases of disease suggested that there are differences in virulence.
We decided to subtype the environmental Legionella strains isolated from health care facilities (HCFs) and to
compare the distribution of strains with the occurrence of hospital-acquired legionellosis.
Methods: Observational ecological study based on the data provided by the regional surveillance of legionellosis
and on data obtained from hospitals environmental monitoring.
Using the monoclonal antibody MAb 3/1 of the Dresden Panel we collected and typed environmental strains of
L. pneumophila sg 1 obtained during routine testing in 56 health care facilities from 2004 to 2009.
The results of the laboratory analyses of the environmental samples were compared with the number of cases
that each health care facility reported during the study period.
Results: The association between the type of colonisation (L. pneumophila sg 1 vs others serogroups) and the
incidence of reported cases was statistically significant (p = 0.03 according to the χ2 test).
Legionella strains with the virulence–associated epitope recognised by MAb 3/1 were isolated in 8 of the 26
HCFs colonised by L. pneumophila sg 1; 7 of the HCFs colonised by MAb 3/1-positive strains accounted for 85%
of the cases of hospital-acquired legionellosis reported during the 6-year study period. There was a statistically
significant association (p = 0.003) between the presence of cases and colonisation by MAb 3/1-positive Legionella strains.
Conclusion: This study suggests that hospitals colonised by more virulent strains should be aware of the increased risk
and consider the opportunities of increase their monitoring efforts and implement more effective contamination control
strategies.
Background
Hospital water systems have been identified as a source
of Legionella pneumonia. Legionella pneumophila ser-
ogroup 1 is the most common cause of legionellosis, a
sporadic and endemic disease that may be acquired from
different environmental sources [1].
The utility of environmental monitoring for Legionella
species remains controversial.
Two different strategies for preventing hospital-acquired
Legionella pneumonia have been advocated. One strategy
emphasises environmental monitoring for Legionella spe-
cies [2], and because the contamination of a hospital’s
water supply by Legionella species can place inpatients at
risk of developing hospital-acquired Legionella pneumonia,
this strategy encourages pneumonia surveillance through
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diagnostic testing. An alternative strategy proposed by the
United States Centers for Disease Control and Prevention
[3] advocates intensive clinical surveillance without routine
environmental surveillance, except in transplant units [4].
National and international guidelines for Legionella pre-
vention and control set risk and intervention threshold
levels for water distribution systems based on the Legion-
ella load detected in samples. Currently, the French guide-
lines [5] are alone in recommending that risk levels be
graded according to the quantity of microorganisms plus
the Legionella species and serogroups present in a hospi-
tal’s water supply. Previously, we reported [6] the findings
of a two-year prospective study on the incidence of
nosocomial legionellosis in hospitals contaminated with
L. pneumophila other than serogroup 1 or non-Legionella
pneumophila species. In the hospitals that only performed
regular ordinary maintenance without carrying out decon-
tamination measures, the results (32 hospitals, 325,703 pa-
tients, only one case of healthcare-associated Legionnaires’
disease reported) confirm that the presence of Legionella
in a hospital’s water distribution system does not necessar-
ily lead to legionellosis [7,8], and in hospitals contaminated
with L. pneumophila non-sg 1, the risk of developing legio-
nellosis is very low.
Worldwide, L. pneumophila sg 1 is the most common
agent of Legionnaires’ disease, accounting for approxi-
mately 80 to 90% of the reported cases [9-11] and approxi-
mately 70% of European travel-associated cases [12]. In
contrast, L. pneumophila sg 2–14 account for only 15 to
20% of community-acquired cases, although they account
for over 50% of the isolates obtained from man-made
aquatic systems. The discrepancy between environmental
isolates and clinical cases of disease has been observed by
Doleans et al. [13], who suggested that there are differ-
ences in virulence rather than greater abundance in water
distribution systems. This discrepancy was also reported
by Harrison et al. [14], who found a higher proportion
of only a few restriction-fragment-length polymorph-
ism (RFLP) types in clinical isolates compared with the
more even distribution of RFLP types seen in environ-
mental isolates.
In Italy, legionellosis is subject to special surveillance
[15]. Physicians who diagnose legionellosis cases, whether
they are hospital or community acquired, notify the local
health authority via normal reporting channels. This infor-
mation is then sent to the regional authorities (Regional
Epidemiological Services for the Monitoring, Prevention
and Control of Infectious Diseases [SeREMI), which then
forward the information to the Ministry of Health, the
Italian National Institute of Statistics (ISTAT) and the Isti-
tuto Superiore di Sanità (ISS). In the last 10 years, 164
hospital-acquired legionellosis cases occurring in Pie-
monte have been reported through this surveillance
network; 112 of these cases were reported at two of
the region’s major hospitals. This marked difference in
the attack rates suggests that the L. pneumophila sg 1
strains in some hospitals may be more pathogenic than
those circulating in hospitals where no cases of legio-
nellosis have been reported. Therefore, we decided to
subtype the Legionella strains isolated during environ-
mental monitoring with monoclonal antibody MAb 3/
1 of the Dresden Panel (corresponding to MAb 2 of
the International Panel) directed against lipopolysac-
charide epitopes on the surface of Legionella cells
[16,17]. According to epidemiological studies, this epi-
tope appears to be associated with virulence [18,19].
One possible explanation for the higher virulence po-
tential of strains carrying the epitope recognised by
MAb 3/1 is that legionellae are more likely to survive
in aerosols, increasing the dose inhaled by exposed in-
dividuals. Immunochemical analysis of the epitope has
suggested that the increased hydrophobicity of these
strains encourages the survival of these legionellae in
aerosols [20]. Gosselin et al. [21] studied the electro-
kinetic patterns of strains carrying the MAb3/1 epitope
and provided a physicochemical explanation for the
role played by the MAb3/1 epitope in Legionella cases.
They demonstrated that virulent MAb3/1-positive strains
have an average flow penetration length (1/λ0) that is
1.5 times larger and a volume charge density (ρ0) that
is approximately 5 times lower than those derived from
less virulent MAb3/1-negative strains.
The infection potential of Legionella pneumophila sg1
strains is most pronounced for bacteria with a low ρ0
and a large λ0 that carry the MAb3/1 epitope. The larger
ρ0 is the more important the repulsion between Legion-
ella pneumophila sg1 and host cell is, and the lower is
the probability of these cells to be infected.
The purpose of this study was to compare the distribu-
tion of L. pneumophila sg 1 monoclonal subtypes ob-
tained during routine sampling in HCFs water systems
with the distribution of hospital-acquired legionellosis,
to assess the risk associated with contaminated environ-
mental reservoirs colonised by more virulent strains.
Methods
Study design
This is an observational ecological study based on the
data provided by the regional surveillance of legionello-
sis and on data obtained from hospitals environmental
monitoring of Legionella.
The number of cases that each health care facility re-
ported was compared to the environmental strains of
Legionella (detected, enumerated and serotyped).
Health care facilities (HCFs)
Altogether 56 HCFs were monitored, 46 were hospitals
and 10 long term care facilities(LTCF).
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The hospitals varied in size: 1250 beds (one hospital),
500–1000 beds (3 hospitals), 200–500 beds (15 hospitals)
and <200 beds (27 hospitals). The mean age of the build-
ings was 40 years, but over the years, the water systems
had been partially renovated.
Over the years, we have gained a fairly complete pic-
ture of the situation at 56 health care facilities (HCFs),
contaminated with Legionella, that implement routine
testing and management interventions. Until 2008, the
majority of HCFs carried out regular controls twice a
year (on a total of 20 samples per year). Since April of
2008, the Piemonte region authorities [22,23] have in-
vited HCF to implement environmental monitoring pro-
grammes that require quarterly sampling of their water
supply and recirculation loops of boilers; this regime
identifies fluctuations in the colonisation of Legionella.
Sampling at distal sites is limited to the facilities where
patients at high risk of infection are hospitalised. In
addition to environmental monitoring, the Piemonte Re-
gional authorities advocate clinical surveillance performed
by the Infection Control Committee, emphasising that
physicians should require Legionella diagnostic tests for
patients with pneumonia.
In the first few years of environmental monitoring, all the
hospitals proved to be contaminated by Legionella spp., al-
though marked differences were seen in terms of microbial
load and types of strains; the most frequently isolated strains
were L. pneumophila serogroups 1, 3, 6. The age and size of
the buildings were not associated with the degree of con-
tamination. The massive contamination found during the
first years of monitoring gradually diminished as a result of
remedial intervention on the water systems monitored [24].
The hospitals were classified according to the Case-
Mix Index (CMI), which was obtained from the Regional
Department of Health (RDH). To calculate the CMI,
RDH used the Medicare Severity-Diagnosis Related
Group (MS-DRG) weights by averaging the MS-DRG
weight of all patients discharged within the calendar.
CMI describes the complexity of cases managed by every
hospital in relation to the average complexity of Italian
hospitals. In this study we used CMI as a confounding
variable and considered the hospitals with a CMI greater
than 1 as facilities with case - complexity higher than
reference, as defined by the Ministry of health.
Long-term care facilities (LTCFs) are establishments
where non-self-sufficient patients who cannot be assisted
at home and can be accommodated for an indefinite
period of time. The majority of patients in these estab-
lishments are elderly, with chronic morbidities and often
confined to bed, conditions that are important risk fac-
tors for infection with Legionella spp. The sizes of these
establishments varied from 30 beds to 177 beds. For the
LTCF the case-mix index was not provided, so we arbi-
trarily assigned a value index < 1.
Diagnosis of Legionellosis
Hospitals performed active surveillance for Legionella in-
fection for all cases of nosocomial pneumonia identified
by clinical, radiological, and laboratory criteria according
to national and international case definition [3,15].
In our setting, if a patient had pneumonia urine
specimens were collected and examined for Legionella
antigen; if the results were negative, the test was re-
peated 5–7 days later. Culture of respiratory secre-
tions when possible was recommended, as was testing
for specific antibodies on the onset of symptoms and
after 15–20 days. Urinary antigen detection is suffi-
cient to start a therapy and initiate an environmental
investigation. The discovery of Legionella in the water
supply led to initiate the disinfection of the plumbing
system.
The following definition integrate the clinical and
microbiological criteria that classify a patient as a noso-
comial case of Legionnaires’ disease and is used for sur-
veillance purposes:
“definite nosocomial” case of Legionnaires’ disease
who was in a hospital or nursing home or other health-
care facility for at least ten days prior to the onset of
symptoms.
The management of active surveillance was assigned
to the hospital’s Infection Control Committee that, in
collaboration with the infection control nurse, collected
data about patients with nosocomial pneumonia and re-
ported this information to the regional surveillance net-
work (SeREMI). During the study period (2004–2009)
this network had reported cases of hospital-acquired
legionellosis that were detected by positive urine antigen
tests; in any cases was available culture of respiratory se-
cretions and species/serogroup information.
This study did not require ethical approval, we only
accessed the number of cases that each health care facil-
ity referred to SeREMI and analyzed virulence only on
environmental samples.
Environmental isolates
We collected data (about 5600 water samples) and envir-
onmental strains obtained from routine testing con-
ducted in 56 HCFs from 2004 to 2009. The water-testing
data and environmental strains for 15 hospitals were
furnished by the Regional Agency for Environmental
Protection (ARPA Piemonte).
Legionella spp. were isolated using a cultural method
according to the ISO 11731 standard technique [25].
Using MAbs 3/1, we typed the 264 environmental
strains collected from the HCFs water supply colonised
by L. pneumophila sg 1. We tested more than one strain
from different years at each HCF to identify possible
variations in the reactivity of MAb3/1, as suggested by
Bernarder et al. [26].
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Monoclonal Subgrouping of isolates
The L. pneumophila sg 1 strains were classified accord-
ing to whether they expressed the virulence-associated
epitope (MAb 3/1-positive) or not (MAb 3/1-negative).
The L. pneumophila sg 1 strains were typed with MAbs
3/1 of the Dresden panel using an indirect immunofluor-
escence test (IIFT) [16,17]. Legionella bacteria were
scraped from BCYE agar, fixed for 10 min in acetone, re-
suspended in distilled water to a concentration of approxi-
mately 3x108 and subjected to indirect immunofluorescence
testing [27]. The MAb 3/1 were used as undiluted cell cul-
ture supernatants, and goat antimouse fluorescein isothio-
cyanate conjugate (polyvalent) (Sigma Aldrich, St Louis,
USA) was used after being diluted 1:64.
Statistical analysis
The χ2 test, Fisher’s exact test and stratification by CMI
were applied to determine whether there was an associ-
ation between legionellosis cases and the type of colon-
isation in the health care facility’s water supply system.
Table 1 Distribution of Legionella and nosocomial













1 1.62 1250 34 Lp1, Lp2-14,
L.spp
+
2 1.1 732 3 Lp1, Lp2-14,
L.spp,
+
3 1.32 559 17 Lp1, Lp2-14,
L.spp,
+
4 0.81 289 8 Lp1, Lp2-14,
L.spp,
+
5 1.06 203 9 Lp1 +
6 1.32 368 4 Lp1, L.spp -
7 1.46 339 1 Lp1, Lp2-14,
L.spp
-
8 1.22 722 1 Lp1, Lp2-14,
Lspp
-
9 0.8 64 0 Lp1, Lspp +
10 1.41 120 0 Lp1, L.spp -
11 0.65 92 0 Lp1, L.spp -
12 0.73 116 0 Lp1, Lp2-14,
L.spp
-
13 0.9 65 0 Lp1, Lp2-14,
Lspp
-
14 0.89 240 0 Lp1, L.spp -
15 0.48 73 0 Lp1, L.spp -
16 0.71 111 0 Lp1, Lp2-14,
Lspp
-
17 0.88 255 0 Lp 1 -
18 1.26 412 0 Lp1, Lp2-14,
Lspp
-
19 0.45 317 0 Lp1, Lp2-14,
Lspp
-
20 1.02 108 0 Lp1, Lp2-14,
Lspp
-
21 1.03 70 0 Lp1, Lp2-14,
Lspp
-
22 0.83 160 1 Lp2-14 n.a
23 0.77 225 1 Lp2-14 n.a.
24 1.12 193 1 Lp2-14, L.spp n.a.
25 1.27 448 1 Lp2-14 n.a.
26 0.92 482 2 Lp2-14, Lspp, n.a
27 0.76 196 0 Lp2-14, Lspp, n.a.
28 0.85 268 0 Lp2-14, Lspp n.a.
29 0.78 57 0 Lp2-14 n.a
30 0.80 86 0 Lp2-14, Lspp, n.a.
31 0.81 90 0 Lp2-14, Lspp n.a.
32 0.80 30 0 Lp2-14, Lspp n.a
33 0.82 54 0 Lp2-14, Lspp n.a.
Table 1 Distribution of Legionella and nosocomial
Legionnaires’ disease among Piemonte health care
facilities (2004–2009) (Continued)
34 0.89 228 0 Lp2-14 n.a.
35 1.19 138 0 Lp2-14 n.a
36 0.93 85 0 Lp2-14 Lspp n.a.
37 0.53 175 0 Lp2-14, Lspp n.a.
38 0.90 242 0 Lp2-14 n.a
39 0.76 72 0 Lp2-14 n.a.
40 0.82 85 0 Lp2-14, Lspp n.a.
41 0.48 482 0 Lp2-14, Lspp n.a.
42 0.76 49 0 Lspp n.a.
43 0.66 73 0 Lp2-14 n.a.
44 1.17 82 0 Lp2-14, Lspp n.a
45 0.87 48 0 Lp3 n.a.
46 0.70 139 0 Lp2-14,Lspp n.a.
47 / 110 2 Lp1, Lp2-14,
L.spp
+
48 / 126 1 Lp1 +
49 / 117 1 Lp1, L.spp -
50 / 174 0 Lp1,Lspp -
51 / 60 0 Lp1 -
52 / 30 0 Lspp n.a
53 / 60 0 Lp2-14 n.a.
54 / 174 0 Lp2-14, Lspp n.a
55 / 60 0 Lp2-14 n.a.
56 / 177 0 Lspp n.a
n.a. = not applicable.
Lp1 = L. pneumophila sg 1; Lp2-14 = L. pneumophila sg 2–14; L. spp = L.
species non-pneumophila.
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For data processing the case-mix index were grouped
into two categories: hospitals with CMI < 1 and hospitals
with CMI > 1.
Results
Table 1 shows the main information (CMI, bed-sites,
number of nosocomial legionellosis cases, colonisation
by Legionella in water system) about the hospitals and
the LCTFs.
Based on the analysis of the strains isolated during en-
vironmental monitoring in the study period, the HCFs
were classified as 1) facilities contaminated by L. pneu-
mophila sg 1 alone or in association with other Legionella
serogroups or species (26/56) or 2) as facilities con-
taminated by one or more L. pneumophila serogroups
(sg 2–14) alone or in association with other Legion-
ella species (30/56).
A total of 87 cases of hospital-acquired legionellosis
were reported to the regional surveillance system (SeR-
EMI) during the study period; the notifications origi-
nated from 16 of the 56 HCFs monitored (Table 1).
Comparing the environmental data with the number of
hospital-acquired legionellosis it emerges that 2 HCFs
colonised with L. pneumophila sg 1 alone reported 10
cases; 5 HCFs that were not colonised with L. pneumo-
phila sg 1 reported 6 cases, the remaining 9 HCFs colo-
nised with several serogroups (L. pneumophila sg 1 and
others serogroups) reported 71 cases.
The association between the type of colonisation (L.
pneumophila sg 1 vs others serogroups) and the inci-
dence of reported cases was statistically significant (p =
0.03 according to the χ2 test) (Table 2). Since diagnosis
of Legionella infection was made by urinary antigen,
linkage between infection and environment can only be
hypothesized; in fact in 9 hospitals there was a colonization
with several serogroups.
Legionella strains with the virulence–associated epi-
tope recognised by MAb 3/1 were isolated in 8 of the 26
HCFs colonised by L. pneumophila sg 1; 7 of the HCFs
colonised by MAb 3/1-positive strains accounted for
85% of the cases of hospital-acquired legionellosis re-
ported during the 6-year study period.
Analysis of isolates during the years of the study
showed variation of reactivity of MAb 3/1only in Hos-
pital No. 9, where it was also isolated a strain 3/1 MAb
negative.
There was a statistically significant association (p =
0.003 according to Fisher’s exact test) between the pres-
ence of cases and colonisation by MAb 3/1-positive Le-
gionella strains (Table 3). One HCF (No. 9) had no cases
of legionellosis even though it was colonised by MAb 3/
1-positive Legionella strains. In contrast, one HCF (No.
6) reported 4 cases even though it was colonised by
MAb 3/1-negative Legionella.
No statistically significant differences (p = 0.7 accord-
ing to Fisher’s exact test) were found in the occurrence
of legionellosis for the HCFs colonised by MAb 3/1-
negative L. pneumophila sg 1 compared with those colo-
nised by L. pneumophila sg 2–14 (Table 4). This result
suggests that there is no greater risk of infection HCFs
in facilities colonised by L. pneumophila sg 1 without
the virulence–associated epitope recognised by MAb 3/1
compared with those colonised by L. pneumophila sg 2–14.
Furthermore, we analysed the 56 HCFs to determine
whether the complexity of care (i.e. the case-mix) was
also an important factor in the occurrence of legionello-
sis (Table 5). To this aim we merged the structures colo-
nized by MAb 3/1-negative L. pneumophila sg 1 with
those colonized by L. pneumophila sg 2–14. Analysis of
the raw data (univariate analysis) showed an association
between the presence of MAb and the presence of cases
(p = 0.0006 by Fisher exact test). With the layering by a
stratifying of the data we found a statistically significant
association between colonisation and reported cases only
in the HCFs classified as CMI < 1 (p = 0.02 according to
Fisher’s exact test).
Discussion
L. pneumophila sg 1 is responsible for the majority of
hospital-acquired infections. Some strains of the L. pneu-
mophila sg 1 population have an enhanced ability to
cause disease: the clinical predominance of L. pneumo-
phila sg 1 strains with specific genotypes suggests that
they have the ability to cause infections in humans
Table 3 Legionellosis cases and colonisation with












sg 1 MAb 3/1 negative
4 14 18
Total 11 15 26
p = 0.003 according to Fisher’s exact test.
Table 2 Association between colonisation with L.







L. pneumophila sg 1 and
other serogroup and species
11 15 26
HCFs colonised with
L. pneumophila sg 2–14 and
other species
5 25 30
Total 16 40 56
p = 0.03 according to the χ2 test.
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[28,29,14]. Among the L. pneumophila sg 1 strains, some
monoclonal subgroups (Knoxville, Philadelphia, Benidorm,
France/Allentown) display the virulence-associated epitope
recognised by MAb 3/1; these strains seem to be associated
with hospital outbreaks, travel-associated infections or
community-acquired infections [26,10]. There are some
published data [10,13,14,30,31] on the serogroup and
monoclonal subgroup distribution of L. pneumophila in
man-made water systems that are associated or not associ-
ated with human disease. This paper describes the first
Italian study in which information about the environmen-
tal distribution of strains according to their MAb 3/1 pro-
file has been examined. This distribution was compared
with the occurrence of legionellosis.
Our laboratory is involved in the environmental moni-
toring of many HCFs in Piemonte (area 25,399 km2;
population 4,446,230); thus, we collected environmental
strains from water systems in HCFs that are representa-
tive of the wider L. pneumophila population in our
region.
The purpose of this study was to compare the distribu-
tion of L. pneumophila sg 1 monoclonal subtypes ob-
tained during routine sampling in 56 man-made HCF
water systems with the distribution of hospital-acquired
legionellosis, to assess the risk associated with contami-
nated environmental reservoirs colonised by more viru-
lent strains.
We could acknowledge two methodological limitation
of this study: first, owing to this investigation being an
ecological study, we didn’t observe the characteristics of
the patients involved and we cannot exclude that we
could not identify and consider some potential con-
founding variables; second, since diagnosis of legionello-
sis in Piemonte is based on urinary antigen detection, it
is not possible an epidemiological comparison between
clinical and environmental strain to confirm the infec-
tion origin.
Of the 56 health care facilities that we monitored, 26
were colonised by L. pneumophila sg 1 alone or in asso-
ciation with other L. pneumophila serogroups. Only 8
(31%) of these facilities were colonised by MAb 3/1-
positive L. pneumophila sg 1, indicating that the total
frequency of colonisation by MAb 3/1-positive L. pneu-
mophila sg 1 was 14% (8/56) among the HCFs. This ob-
servation aligns with the findings of other studies that
most environmental isolates are MAb 3/1-negative, in
contrast to human isolates [10,32-34]. The comparison
between the environmental data and the data on the
cases of Legionnaires’ disease showed that 93% of the
cases (81/87) occurred in the HCFs colonised by L.
pneumophila sg 1 alone or with others serogroups.
Among the L. pneumophila sg 1 strains, the monoclonal
subgroup with the virulence-associated epitope recog-
nised by MAb 3/1 was isolated in 27% (7/26) of the hos-
pitals, which had reported 85% (74/87) of the cases
(Table 1). Only one health care facility colonised by
MAb 3/1-positive L. pneumophila sg 1 (No. 9, Table 1)
had no reported cases of legionellosis. From 2004 to
2006 this hospital had two medical wards (64 beds)
while from 2005 to 2009 was no longer an hospital but
was intended only for hemodialysis center. Moreover in
this hospital was highlighted a variation of the reactivity
of MAb 3/1 from positive to negative.
Only one health care facility colonised by MAb 3/1-
negative L. pneumophila sg 1 (No. 6, Table 1) reported
four cases of legionellosis. Despite the epidemological in-
vestigation, the infection sources remained unknown.
Health authorities hypothesized the involvement of the
cooling towers of a supermarket in the nearby of the
hospital.
The epidemiological data for Piemonte (Table 1) show
that the reporting rates are particularly high at hospitals that
admit patients with severe illnesses; therefore, we analysed
the relationship between CMI, MAb and hospital-acquired
Table 5 Association of MAb 3/1, CMI and reported cases
a) HCF b) HCF with CMI < 1 c) HCF with CMI >1












Negative(a) 39 9 33 4 6 5
Positive 1 7 1 3 0 4
p = 0.0006 p = 0.02 p = 0.18
(Fisher’s exact test) (Fisher’s exact test) (Fisher’s exact test)
(a) both the HCF colonized by L. pneumophila. sg 1 MAb 3/1 negative, and all other structures colonized by L. pneumophila sg 2–14.
Table 4 Legionellosis cases in health care facilities
colonised with L. pneumophila sg 2–14 and/or L.











L. pneumophila sg 2-14
5 25 30
Total 9 39 48
p = 0.7 according to Fisher’s exact test.
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infections in the 56 HCFs. As shown in Table 5, we found a
statistically significant relationship between the presence of
strains MAb 3/1 positive in the environment and the occur-
rence of cases of legionellosis. After stratification for CMI,
the association was confirmed only for low-complexity hos-
pitals (CMI < 1) while disappeared for high complexity hos-
pitals (CMI > 1). These results might suggest that the
subjects with less severe illnesses may need more virulent
strains to get sick while patient with severe underlying dis-
ease, hospitalised in facilities with CMI > 1, were more sus-
ceptible to becoming infected even by less aggressive strains.
This observation aligns with the findings of Helbig and col-
leagues [10], who found that most clinical isolates in hospi-
tals are MAb 3/1-negative.
Conclusions
Our study suggests that MAb 3/1 subtyping of L. pneu-
mophila sg 1 strains may be useful for assessing the risk
associated with contaminated environmental reservoirs.
Hospitals colonised by more virulent strains should be
advised to increase their case monitoring efforts and to
implement more effective contamination control strat-
egies. Many of the guidelines and official recommenda-
tions for preventing the transmission of Legionnaires’
disease recommend action items based solely on certain
concentrations of legionellae or on the number of sites
that are positive for the bacteria [35,36]. None of these
guidelines discriminate among the large number of Le-
gionella species or serogroups, even though it is clear
that they differ in their capacity to cause disease. Better
characterisation of the strains that cause the majority of
diseases would allow for more targeted intervention
measures.
Our results support the opinion stated by Harrison et al.
[14]. That “knowing which particular strain is present in
an environment might be at least as important as knowing
the quantity in which legionellae are present”.
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